bpc159 vs bpc 157 BPC-157 Explained: Benefits, Safety & Oral Injectable Options Unlocking the Power of Peptides:

In a 2-year trial involving patients with type 2 diabetes mellitus (T2DM) and high cardiovascular risk, more events of diabetic retinopathy complications occurred in the patients treated with semaglutide injection (3%) compared to placebo (1.8%)

When blood glucose drops below normal levels (typically below 4.0 mmol/L), the body releases adrenaline as a counter-regulatory response, which can cause tremor, sweating, palpitations, and a jittery feeling

BPC-157 is a synthetic peptide derived from a sequence originally identified in gastric proteins

and there is the potential to use them in combination with other agents